These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 23542116)
1. Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection. Bolla PA; Carasi P; Bolla Mde L; De Antoni GL; Serradell Mde L Anaerobe; 2013 Jun; 21():28-33. PubMed ID: 23542116 [TBL] [Abstract][Full Text] [Related]
2. Kefir-isolated Lactococcus lactis subsp. lactis inhibits the cytotoxic effect of Clostridium difficile in vitro. Bolla PA; Carasi P; Serradell Mde L; De Antoni GL J Dairy Res; 2013 Feb; 80(1):96-102. PubMed ID: 23217732 [TBL] [Abstract][Full Text] [Related]
3. Effect of freeze-drying on viability and in vitro probiotic properties of a mixture of lactic acid bacteria and yeasts isolated from kefir. Bolla PA; Serradell Mde L; de Urraza PJ; De Antoni GL J Dairy Res; 2011 Feb; 78(1):15-22. PubMed ID: 20822567 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis. Trejo FM; De Antoni GL; Pérez PF J Dairy Res; 2013 Aug; 80(3):263-9. PubMed ID: 23611644 [TBL] [Abstract][Full Text] [Related]
5. Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters. Anton PM; O'Brien M; Kokkotou E; Eisenstein B; Michaelis A; Rothstein D; Paraschos S; Kelly CP; Pothoulakis C Antimicrob Agents Chemother; 2004 Oct; 48(10):3975-9. PubMed ID: 15388461 [TBL] [Abstract][Full Text] [Related]
6. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. Naaber P; Mikelsaar RH; Salminen S; Mikelsaar M J Med Microbiol; 1998 Jul; 47(7):591-8. PubMed ID: 9839563 [TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile typhlitis associated with cecal mucosal hyperplasia in Syrian hamsters. Ryden EB; Lipman NS; Taylor NS; Rose R; Fox JG Lab Anim Sci; 1991 Dec; 41(6):553-8. PubMed ID: 1667196 [TBL] [Abstract][Full Text] [Related]
8. Lactic acid bacteria and yeasts in kefir grains and kefir made from them. Simova E; Beshkova D; Angelov A; Hristozova Ts; Frengova G; Spasov Z J Ind Microbiol Biotechnol; 2002 Jan; 28(1):1-6. PubMed ID: 11938463 [TBL] [Abstract][Full Text] [Related]
9. Investigation on culturable microflora in Tibetan kefir grains from different areas of China. Gao J; Gu F; Abdella NH; Ruan H; He G J Food Sci; 2012 Aug; 77(8):M425-33. PubMed ID: 22860591 [TBL] [Abstract][Full Text] [Related]
10. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins. O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406 [TBL] [Abstract][Full Text] [Related]
11. Surface proteins from Lactobacillus kefir antagonize in vitro cytotoxic effect of Clostridium difficile toxins. Carasi P; Trejo FM; Pérez PF; De Antoni GL; Serradell Mde L Anaerobe; 2012 Feb; 18(1):135-42. PubMed ID: 22126976 [TBL] [Abstract][Full Text] [Related]
12. Metabolic activity and symbiotic interactions of lactic acid bacteria and yeasts isolated from water kefir. Stadie J; Gulitz A; Ehrmann MA; Vogel RF Food Microbiol; 2013 Sep; 35(2):92-8. PubMed ID: 23664259 [TBL] [Abstract][Full Text] [Related]
13. Infection of hamsters with epidemiologically important strains of Clostridium difficile. Sambol SP; Tang JK; Merrigan MM; Johnson S; Gerding DN J Infect Dis; 2001 Jun; 183(12):1760-6. PubMed ID: 11372028 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet. Blankenship-Paris TL; Chang J; Dalldorf FG; Gilligan PH Lab Anim Sci; 1995 Feb; 45(1):47-53. PubMed ID: 7752614 [TBL] [Abstract][Full Text] [Related]
15. New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Merrigan MM; Sambol SP; Johnson S; Gerding DN Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S46-50. PubMed ID: 19303570 [TBL] [Abstract][Full Text] [Related]
16. Colonization for the prevention of Clostridium difficile disease in hamsters. Sambol SP; Merrigan MM; Tang JK; Johnson S; Gerding DN J Infect Dis; 2002 Dec; 186(12):1781-9. PubMed ID: 12447764 [TBL] [Abstract][Full Text] [Related]
17. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Hickson M; D'Souza AL; Muthu N; Rogers TR; Want S; Rajkumar C; Bulpitt CJ BMJ; 2007 Jul; 335(7610):80. PubMed ID: 17604300 [TBL] [Abstract][Full Text] [Related]
18. Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice. Kaur S; Vaishnavi C; Ray P; Kochhar R; Prasad KK J Gastroenterol Hepatol; 2010 Apr; 25(4):832-8. PubMed ID: 20074161 [TBL] [Abstract][Full Text] [Related]
19. Toxigenicity and adherence in Clostridium difficile strains isolated from patients with and without diarrhoea. González-Valencia G; Muñoz O; Torres JF Arch Invest Med (Mex); 1991; 22(2):189-96. PubMed ID: 1819993 [TBL] [Abstract][Full Text] [Related]
20. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. Geric B; Carman RJ; Rupnik M; Genheimer CW; Sambol SP; Lyerly DM; Gerding DN; Johnson S J Infect Dis; 2006 Apr; 193(8):1143-50. PubMed ID: 16544255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]